BIOGEN INC (1BIIB.MI) Forecast, Price Target & Analyst Ratings

BIT:1BIIB • US09062X1037

Current stock price

151.34 EUR
-8.46 (-5.29%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOGEN INC (1BIIB.MI).

Forecast Snapshot

Consensus Price Target

Price Target
€182.03
+ 20.28% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$3.06
Revenue Estimate
2.299B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
73.02%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€182.03
Upside
+ 20.28%
From current price of €151.34 to mean target of €182.03, Based on 43 analyst forecasts
Low
€130.14
Median
€176.12
High
€248.04

Price Target Revisions

1 Month
11.45%
3 Months
19.95%

Price Target Summary

43 Wall Street analysts provided a forecast for the next 12 months for 1BIIB.MI. The average price target is 182.03 EUR. This implies a price increase of 20.28% is expected in the next year compared to the current price of 151.34.
The average price target has been revised upward by 19.95% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

1BIIB Current Analyst Rating1BIIB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15 20

Analyst Ratings History

1BIIB Historical Analyst Ratings1BIIB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30 40

Analyst Ratings Consensus

ChartMill Buy Consensus
73.02%
1BIIB.MI was analyzed by 43 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about 1BIIB.MI.
In the previous month the buy percentage consensus was at a similar level.
1BIIB.MI was analyzed by 43 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
$3.06
Revenue Estimate
2.299B
Revenue Q2Q
-5.43%
EPS Q2Q
1.34%
Number of Analysts
30

Next Earnings Revisions

Revenue (1 Month)
0.61%
Revenue (3 Months)
-0.22%
EPS (1 Month)
-2.21%
EPS (3 Months)
-15.12%

Next Earnings Summary

1BIIB.MI is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 3.06 EUR and the consensus revenue estimate is 2.30B EUR.
The next earnings revenue estimate has been revised downward by 0.22% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
1BIIB.MI revenue by date.1BIIB.MI revenue by date.
9.836B
-3.32%		9.676B
-1.62%		9.891B
2.22%		9.667B
-2.26%		9.633B
-0.35%		9.75B
1.21%		9.724B
-0.27%		9.783B
0.61%		9.545B
-2.43%		9.559B
0.15%		9.338B
-2.31%
EBITDA
YoY % growth
1BIIB.MI ebitda by date.1BIIB.MI ebitda by date.
2.669B
-28.68%		3.325B
24.56%		3.572B
7.45%		3.353B
-6.14%		3.238B
-3.43%		3.322B
2.59%		3.304B
-0.54%		3.052B
-7.63%		3.959B
29.72%		4.377B
10.56%		4.838B
10.53%
EBIT
YoY % growth
1BIIB.MI ebit by date.1BIIB.MI ebit by date.
2.174B
-32.56%		2.651B
21.94%		2.793B
5.32%		2.938B
5.21%		2.969B
1.06%		3.083B
3.84%		3.083B3.051B
-1.04%		3.212B
5.28%		3.33B
3.67%		3.139B
-5.74%
Operating Margin
1BIIB.MI operating margin by date.1BIIB.MI operating margin by date.
22.11%27.40%28.23%30.39%30.82%31.62%31.71%31.19%33.65%34.84%33.62%
EPS
YoY % growth
1BIIB.MI eps by date.1BIIB.MI eps by date.
15.08
-18.27%		16.47
9.22%		15.29
-7.16%		16.12
5.45%		16.35
1.40%		17.19
5.15%		18.09
5.25%		18.19
0.51%		18.47
1.53%		19.17
3.84%		18.53
-3.39%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		3.06
1.34%		4.33
-20.76%		4.30
-10.51%		4.02
101.80%		3.69
20.72%		4.55
5.00%		4.36
1.28%		4.58
14.15%
Revenue
Q2Q % growth		2.299B
-5.43%		2.46B
-7.01%		2.514B
-0.82%		2.499B
9.63%		2.263B
-1.57%		2.442B
-0.73%		2.446B
-2.70%		2.426B
-2.92%
EBITDA
Q2Q % growth		616.22M
-28.53%		815.78M
-37.36%		835.11M
-34.45%		844.16M
-32.19%		N/AN/AN/AN/A
EBIT
Q2Q % growth		545.53M
-19.66%		792.17M
-14.35%		798.66M
15.01%		729.07M
56.79%		553.44M
1.45%		727.03M
-8.22%		709.14M
-11.21%		696.4M
-4.48%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

1BIIB.MI Yearly Revenue VS Estimates1BIIB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B
1BIIB.MI Yearly EPS VS Estimates1BIIB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
3.98%
EPS Next 5 Year
3.53%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-0.91%
Revenue Next 5 Year
-0.48%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
5.07%
EBIT Next 5 Year
1.28%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BIOGEN INC / 1BIIB.MI Forecast FAQ

What is the average price target for BIOGEN INC (1BIIB.MI) stock?

43 analysts have analysed 1BIIB.MI and the average price target is 182.03 EUR. This implies a price increase of 20.28% is expected in the next year compared to the current price of 151.34.

When does BIOGEN INC (1BIIB.MI) report earnings?

BIOGEN INC (1BIIB.MI) will report earnings on 2026-04-29.

What are the consensus estimates for 1BIIB stock next earnings?

The consensus EPS estimate for the next earnings of BIOGEN INC (1BIIB.MI) is 3.06 EUR and the consensus revenue estimate is 2.30B EUR.

What is the consensus rating for BIOGEN INC (1BIIB.MI) stock?

The consensus rating for BIOGEN INC (1BIIB.MI) is 73.0233 / 100 . This indicates that analysts generally have a positive outlook on the stock.